Gsk Quarterly Results 2025 – London-listed pharma giant GSK has raised its guidance after a strong second quarter beat market expectations, boosted by its cancer and HIV portfolio. . SOUTH SAN FRANCISCO, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the first .

Gsk Quarterly Results 2025

Source : www.gsk.com

GSK Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Source : finance.yahoo.com

Events calendar | GSK

Source : www.gsk.com

GSK First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Source : finance.yahoo.com

GSK Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS

Source : simplywall.st

GSK delivers strong 2023 performance and upgrades growth outlooks

Source : www.gsk.com

GSK Second Quarter 2023 Earnings: Beats Expectations

Source : finance.yahoo.com

Cameron Burbank Silicon Valley Bank | LinkedIn

Source : www.linkedin.com

GSK Pharma Q1 Results 2024 🔴 GSK Results 🔴 Glaxosmithkline Share

Source : www.youtube.com

Dirk Haussecker on X: “$ME launching genetic study to understand

Source : twitter.com

Gsk Quarterly Results 2025 GSK delivers strong 2023 performance and upgrades growth outlooks : GSK reported second-quarter core earnings per share (EPS) of 43.4 pence on sales of £7.88 billion, beating analysts’ average forecasts of 38.9 pence and £7.51 billion respectively, according to . GSK(LON:GSK)’s second-quarter results exceeded expectations with strong sales and profits, leading to an upward revision of the outlook. However, a cut in the vaccine sales target has led to a dip in .